Maridebart cafraglutide Antibody
Maridebart cafraglutide is an antibody-peptide conjugate that functions as a dual GLP-1 receptor agonist and GIP receptor antagonist. It has demonstrated efficacy in reducing body weight and improving metabolic parameters in preclinical in vivo studies using obese male mice and cynomolgus monkeys, highlighting its utility for obesity and metabolic disease research.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), Glucagon Receptor
Conjugation
Unconjugated
Field of Research
Pharmacology & Drug Discovery
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PB9249-Fluoro488 100 µg/Vial
Anti-CD8 alpha/CD8A Antibody Picoband® Fluoro488 Conjugated
Sign In for Pricing
View Details 
GTR15119175 1 Vial
Lentiviral human ARMC1 shRNA (UAS) - Lentiviral human ARMC1 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 
362441 200 µL
CD109 (Differentiation 109, CPAMD7, p180, r150, Gov platelet alloantigens, 150kD TGF-beta-1-binding protein, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7)
Sign In for Pricing
View Details